Title:
FUSOSOME COMPOSITIONS FOR CNS DELIVERY
Document Type and Number:
WIPO Patent Application WO/2020/102499
Kind Code:
A3
Abstract:
The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a fusogen, a positive target cell- specific regulatory element, and a non-target cell- specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.
More Like This:
Inventors:
VON MALTZAHN GEOFFREY (US)
RUBENS JACOB (US)
SHAH JAGESH (US)
RUZO MATIAS ALBERT (US)
PUCCI FERDINANDO (US)
MILWID JOHN (US)
MEE MICHAEL (US)
GORDON NEAL (US)
RUBENS JACOB (US)
SHAH JAGESH (US)
RUZO MATIAS ALBERT (US)
PUCCI FERDINANDO (US)
MILWID JOHN (US)
MEE MICHAEL (US)
GORDON NEAL (US)
Application Number:
PCT/US2019/061424
Publication Date:
July 23, 2020
Filing Date:
November 14, 2019
Export Citation:
Assignee:
FLAGSHIP PIONEERING INNOVATIONS V INC (US)
International Classes:
A61K9/127; C12N15/88
Domestic Patent References:
WO2010053489A1 | 2010-05-14 | |||
WO2006078221A1 | 2006-07-27 |
Foreign References:
US20050070493A1 | 2005-03-31 |
Attorney, Agent or Firm:
KOYFMAN, Hannah, R. et al. (US)
Download PDF: